Stay updated on Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial
Sign up to get notified when there's something new on the Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial page.

Latest updates to the Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial page
- Check5 days agoChange DetectedSite-wide notice about a lapse in government funding with links to cc.nih.gov and opm.gov is now displayed. The footer shows a software revision from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check12 days agoChange DetectedThe updates are minor UI/metadata changes: a new 'Show glossary' option appears, and small capitalization/terminology edits (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data') along with a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedMinor site revision update from v3.3.3 to v3.3.4; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedFooter now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed. These changes do not affect the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page. This appears to be a minor update with no changes to the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedRemoved the government funding disclaimer banner that warned the site may be out of date due to funding lapses and directed users to operating-status information.SummaryDifference0.5%

Stay in the know with updates to Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial page.